Novavax Inc (NVAX)
3.95
-0.20
(-4.82%)
USD |
NASDAQ |
Apr 25, 16:00
3.98
+0.03
(+0.76%)
After-Hours: 20:00
Novavax Revenue (Quarterly): 253.40M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 253.40M |
| September 30, 2023 | 22.06M |
| June 30, 2023 | 424.43M |
| March 31, 2023 | -6.428M |
| December 31, 2022 | 287.83M |
| September 30, 2022 | 628.30M |
| June 30, 2022 | 185.92M |
| March 31, 2022 | 604.67M |
| December 31, 2021 | -726.51M |
| September 30, 2021 | 178.84M |
| June 30, 2021 | 298.02M |
| March 31, 2021 | 447.23M |
| December 31, 2020 | -173.55M |
| September 30, 2020 | 157.02M |
| June 30, 2020 | 35.54M |
| March 31, 2020 | 3.377M |
| December 31, 2019 | 8.816M |
| September 30, 2019 | 2.507M |
| June 30, 2019 | 3.357M |
| March 31, 2019 | 3.982M |
| December 31, 2018 | 6.127M |
| September 30, 2018 | 7.735M |
| June 30, 2018 | 10.77M |
| March 31, 2018 | 9.653M |
| December 31, 2017 | 10.41M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.352M |
| June 30, 2017 | 6.732M |
| March 31, 2017 | 5.68M |
| December 31, 2016 | 5.399M |
| September 30, 2016 | 3.231M |
| June 30, 2016 | 2.505M |
| March 31, 2016 | 4.218M |
| December 31, 2015 | 5.853M |
| September 30, 2015 | 6.525M |
| June 30, 2015 | 14.00M |
| March 31, 2015 | 9.877M |
| December 31, 2014 | 6.724M |
| September 30, 2014 | 8.214M |
| June 30, 2014 | 8.259M |
| March 31, 2014 | 7.462M |
| December 31, 2013 | 8.748M |
| September 30, 2013 | 4.802M |
| June 30, 2013 | 3.531M |
| March 31, 2013 | 3.833M |
| December 31, 2012 | 4.566M |
| September 30, 2012 | 5.765M |
| June 30, 2012 | 7.103M |
| March 31, 2012 | 4.642M |
| December 31, 2011 | 5.845M |
| September 30, 2011 | 5.008M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-726.51M
Minimum
Dec 2021
628.30M
Maximum
Sep 2022
138.68M
Average
157.02M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| Pfizer Inc | 14.25B |
| Moderna Inc | 2.813B |
| Agilent Technologies Inc | 1.658B |
| Lexicon Pharmaceuticals Inc | 0.702M |
| Vaxart Inc | 6.625M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -178.39M |
| Total Expenses (Quarterly) | 436.97M |
| EPS Diluted (Quarterly) | -1.47 |
| Enterprise Value | 180.32M |
| Gross Profit Margin (Quarterly) | 38.84% |
| Profit Margin (Quarterly) | -70.40% |
| Earnings Yield | -140.9% |
| Normalized Earnings Yield | -140.94 |